MACROPHAGE-ELECTROPHORETIC-MOBILITY (M.E.M.) TEST FOR MALIGNANT DISEASE: An Independent Confirmation

Abstract The validity of a new in-vitro bloodtest for cancer, which depends on the sensitisation of the patient's lymphocytes to a common antigen apparently present in human tumours, has been independently confirmed.